caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1023229242

Elizabeth HarrisM.D.

PRACTICEMONTEFIORE MEDICAL CENTERSee all providers at this practice →
Internal MedicineBronx, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
113
Unique beneficiaries
—
Total services
147
Distinct HCPCS
5
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — bottom quintile (cohort median 552).
REFERRAL NETWORK

Where Elizabeth Harris's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
New York City Health And Hospitals Corporation
Ambulance Service Provider · Brooklyn, NY
1137
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MONTEFIORE MEDICAL CENTER140846
MONTEFIORE MEDICAL CENTER1431
PORRECA, FRANCIS1140
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330059
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
4,337
Beneficiaries
—
Total drug cost
$613K
Distinct drugs
89
Brand share
29.8%
Top prescribed drugs
Atorvastatin Calcium483 claims
Amlodipine Besylate199 claims
Lisinopril158 claims
Omeprazole153 claims
Metformin Hcl152 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
27.5
Cost
68.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.